Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04150042
What this trial is testing

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

Who this might be right for
Pancreatic Adenocarcinoma MetastaticBRCA1 MutationBRCA2 Mutation+17 more
General Oncology, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06602323
What this trial is testing

TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652165
What this trial is testing

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

Who this might be right for
DLBCL
Ruijin Hospital 66
Large-scale testing (Phase 3)Active Not RecruitingNCT05022901
What this trial is testing

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

Who this might be right for
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
Delcath Systems Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00591630
What this trial is testing

Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation

Who this might be right for
Diffuse Large Cell LymphomaLymphoma
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Active Not RecruitingNCT00602641
What this trial is testing

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 306
Large-scale testing (Phase 3)Ended earlyNCT04649060
What this trial is testing

Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRelapsed-Refractory Multiple Myeloma
Oncopeptides AB 54
Post-approval studies (Phase 4)UnknownNCT05855122
What this trial is testing

Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital of Soochow University 48
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Study completedNCT00482846
What this trial is testing

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Who this might be right for
MucositisMultiple Myeloma
Barbara Ann Karmanos Cancer Institute 38
Not applicableLooking for participantsNCT06879847
What this trial is testing

A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 40
Early research (Phase 1)WithdrawnNCT00504101
What this trial is testing

Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Miami
Testing effectiveness (Phase 2)UnknownNCT02572492
What this trial is testing

Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support

Who this might be right for
Multiple Myeloma
Henrik Gregersen 200
Large-scale testing (Phase 3)UnknownNCT00747877
What this trial is testing

High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Leeds Cancer Centre at St. James's University Hospital 460
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Ended earlyNCT00539500
What this trial is testing

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
M.D. Anderson Cancer Center 3
Very early researchLooking for participantsNCT03964506
What this trial is testing

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia+4 more
Omar Aljitawi 24
Testing effectiveness (Phase 2)Study completedNCT00651937
What this trial is testing

Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden

Who this might be right for
Multiple MyelomaPrimary Amyloidosis
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT00064337
What this trial is testing

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network 104
Testing effectiveness (Phase 2)Study completedNCT00038831
What this trial is testing

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 47
Next Page